Discover 272 paid clinical trials in Concord, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 272
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
for
Bone Metastases
Location: Lebanon NH, New York NY, Ann Arbor MI, Savannah GA,
Sponsor: American College of Radiology - Image Metrix
Sex: All
Age: 18+
Code: NCT00882609
Phase3, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Lebanon NH, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Lebanon NH, Boston MA, Morristown NJ,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase1, Recruiting
Effects of Social Feedback on Intracranial EEG
for
Social Influence, Epilepsy
Location: Lebanon NH
Sponsor: Trustees of Dartmouth College
Sex: All
Age: 18 - 65
Code: NCT06975800
Recruiting
Telmisartan in Prostate Cancer
for
Prostate Cancer
Location: Lebanon NH
Sponsor: Tyler J Curiel
Sex: Male
Age: 18+
Code: NCT06168487
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
for
Kidney Cancer
Location: Lebanon NH, Boston MA, Bronx NY, Pittsburgh PA,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT00301990
Phase2, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Lebanon NH, New Haven CT, Riverhead NY,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Lebanon NH, Burlington MA, Boston MA, Providence RI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Lebanon NH, Boston MA, New Haven CT, Roslyn NY,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Lebanon NH, White River Junction VT, Boston MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Lebanon NH, Boston MA, Providence RI, Montreal,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study